Treatment of Hyperphosphatemia in Chronic Kidney Disease Stages 1 to 3
Clinical Scenario
Patients with chronic kidney disease (CKD) stages 1 to 3 and a serum phosphorus concentration above 4.5 mg/dL — the threshold defining hyperphosphatemia. At these earlier stages of CKD, phosphorus elevation can often be addressed without escalating to more complex therapies.
Treatment Approach
In CKD stages 1 to 3, the protocol centres on a targeted dietary modification strategy. The specific components of that approach, the clinical decision points, and the full sequencing are detailed in the complete regimen.
Treatment Target
The goal is to normalise serum phosphorus into the range of 2.7 – 4.6 mg/dL in patients not receiving dialysis.
References
Hyperphosphatemia is defined by a serum phosphorus concentration of >4.5 mg/dL (1.45 mmol/L).
Hyperphosphatemia in CKD stages 1 to 3 can typically be controlled with dietary changes.
Dietary restriction of phosphate and protein is considered effective for most minor elevations of phosphorus.
In general, the goal is to achieve a phosphorus concentration of 2.7 to 4.6 mg/dL in patients not receiving dialysis.
View source ↗